ACC 2024 – Plozasiran effective for severe hypertriglyceridemia in patients at high risk of pancreatitis
Patients with severely elevated triglyceride levels who are therefore at risk of developing acute pancreatitis have achieved a 74% average reduction in triglyceride levels, when treated for 24… read more.
